v3.26.1
Document And Entity Information - USD ($)
12 Months Ended
Mar. 31, 2026
Jun. 19, 2026
Sep. 30, 2025
Document Information Line Items      
Entity Registrant Name Cineverse Corp.    
Trading Symbol CNVS    
Document Type 10-K    
Current Fiscal Year End Date --03-31    
Entity Common Stock, Shares Outstanding   23,417,021  
Entity Public Float     $ 57,567,511
Amendment Flag false    
Entity Central Index Key 0001173204    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Mar. 31, 2026    
Document Fiscal Year Focus 2026    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-31810    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 22-3720962    
Entity Address, Address Line One 224 W. 35th St.,    
Entity Address, Address Line Two Suite 500 #947,    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10001    
City Area Code (212)    
Local Phone Number 206-8600    
Title of 12(b) Security CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Document Financial Statement Error Correction [Flag] false    
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

None.

   
Auditor Firm ID 274    
Auditor Name EISNERAMPER LLP    
Auditor Location Iselin, New Jersey    
Auditor Opinion

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Cineverse Corp. (the “Company”) as of March 31, 2026 and 2025, and the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of March 31, 2026 and 2025, and the consolidated results of its operations and its cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.